Pregnancy is a period in which every woman should enjoy and prepare for the most important and beautiful role in life, but the fact is that during this period, one must often visit the doctor and undergo certain analyses and check-ups. It is important to ensure that there are no health complications for both the mother and the baby. Pregnancy is also a time of great anticipation, often accompanied by anxiety. There is no mother who doesn't worry about whether the baby will have health problems. The good news is that most babies are born healthy, but it is also good to know that expectant parents have the opportunity to get details about the baby's health as early as the 10th week of pregnancy.
During pregnancy, two types of prenatal tests can be done:
- Screening tests (double test, triple test, quadriple test, NIPT)
- Diagnostic tests (amniocentesis, chorionic villus sampling...)
Non-invasive prenatal tests like our NIPTiva test are intended for absolutely all expectant mothers who want a peaceful, safe, and calm pregnancy. The test can be done as early as the 10th week of pregnancy. The NIPTiva test enables you to avoid invasive diagnostic tests such as amniocentesis, which is performed between 16-18 weeks of pregnancy, and the results are awaited for a minimum of 2 weeks. Therefore, only if the NIPT test shows a poor result, the doctor will refer you for invasive diagnostics. A normal NIPT test result means that further diagnostics are not necessary.
NIPTiva prenatal tests are the fastest and most modern version performed on the Illumina platform. They provide a significantly more thorough and detailed approach to the analysis of genetic abnormalities with 99.9% reliability. The Illumina platform is the most reliable platform in the world, and all other platforms are actually attempts to copy its technologies, but no platform has been able to be as reliable as Illumina. It can be said that every pregnancy carries a risk of chromosomal abnormalities, regardless of age, family history, or overall health of the pregnant woman. Even if there is a 95% chance of having a healthy baby, errors can occur during DNA replication for no apparent reason, leading to chromosomal abnormalities that are not hereditary. This is precisely why screening tests are important in early pregnancy.
Who is recommended to have a non-invasive prenatal test?
The NIPTiva prenatal non-invasive test is necessary for all pregnant women who want to ensure that their fetus does not have genetic anomalies. It is especially necessary for pregnant women who are over 30 years old at the time of delivery. All women who have had miscarriages or whose babies had genetic anomalies in previous pregnancies need to undergo this testing. The NIPTiva prenatal test can detect Down syndrome in pregnancy with a reliability of 99.9%. We must emphasize that double and triple tests may miss, or fail to recognize, up to 15% of pregnancies with Down syndrome. The NIPTiva test can detect Down syndrome, Edwards syndrome, Patau syndrome, X and Y chromosome aneuploidies, microdeletions and duplications, and autosomal trisomies. Determining the sex is also possible with this test, so it can be done as early as the 10th week of pregnancy. The NIPTiva test can be done in both singleton and twin pregnancies, and the procedure involves standard venous blood sampling from the mother's arm.
Your chosen gynecologist will definitely recommend that you take this test if you are:
- A pregnant woman with a singleton pregnancy aged 30 or over
- A pregnant woman with a twin pregnancy
- A pregnant woman who has had previous spontaneous miscarriages
- A pregnant woman who has achieved pregnancy through IVF fertilization (including egg donations)
- A pregnant woman with a family history of genetic disorders
- A pregnant woman with a poor ultrasound or double/triple test result
An increasing number of pregnant women are opting for these non-invasive prenatal tests to be sure that everything is fine with their baby's health. We should take advantage of all the benefits that modern technology provides us, and avoid the discomfort of invasive methods such as amniocentesis, and that is precisely what NIPTiva tests offer us.